FDA Inspection 1030399 — Astellas Pharma US Inc.
The FDA completed an inspection of Astellas Pharma US Inc. on September 1, 2017 in Northbrook, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 1, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Northbrook, IL (United States)
Additional Details
Sponsor, Contract Research Organization